BTC of New Bedford is a clinical research site located in New Bedford, Massachusetts, United States 02740.
Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.
BTC of New Bedford has participated in 21 clinical trials with 3 currently active.
Therapeutic areas: Depressive Disorder, Major, Intermittent Explosive Disorder, Alzheimer Disease.
Sponsors: Janssen Research & Development, LLC, Otsuka Pharmaceutical Development & Commercialization, Inc., AriBio Co., Ltd..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Massachusetts · View every site in New Bedford
Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
BTC of New Bedford has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
BTC of New Bedford has 21 clinical trials on record, with 3 currently active. Their work covers Depressive Disorder, Major, Intermittent Explosive Disorder, Alzheimer Disease.
BTC of New Bedford has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.